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Abstract
FK506 binding proteins (FKBPs), also called immunophilins, are prolyl-isomerases (PPIases) that participate in a wide variety
of cellular functions including hormone signaling and protein folding. Recent studies indicate that proteins that contain
PPIase activity can also alter the processing of Alzheimer’s Amyloid Precursor Protein (APP). Originally identified in
hematopoietic cells, FKBP52 is much more abundantly expressed in neurons, including the hippocampus, frontal cortex, and
basal ganglia. Given the fact that the high molecular weight immunophilin FKBP52 is highly expressed in CNS regions
susceptible to Alzheimer’s, we investigated its role in Ab toxicity. Towards this goal, we generated Ab transgenic Drosophila
that harbor gain of function or loss of function mutations of FKBP52. FKBP52 overexpression reduced the toxicity of Ab and
increased lifespan in Ab flies, whereas loss of function of FKBP52 exacerbated these Ab phenotypes. Interestingly, the Ab
pathology was enhanced by mutations in the copper transporters Atox1, which interacts with FKBP52, and Ctr1A and was
suppressed in FKBP52 mutant flies raised on a copper chelator diet. Using mammalian cultures, we show that FKBP52 (2/2)
cells have increased intracellular copper and higher levels of Ab. This effect is reversed by reconstitution of FKBP52. Finally,
we also found that FKBP52 formed stable complexes with APP through its FK506 interacting domain. Taken together, these
studies identify a novel role for FKBP52 in modulating toxicity of Ab peptides.
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Introduction
FKBP52 is a high molecular weight FK506-binding immuno-
philin, possessing peptidyl-prolyl isomerase (PPIase) activity. It was
first identified as a component of steroid hormone receptor hetero-
complexes [1] and recently shown to regulate the nuclear
localization of the glucocorticoid receptor [2]. It is widely
expressed in mammalian tissues including the brain [3] and
immunophilins FKBP12 and FKBP52 are up-regulated in
regenerating neurons suggesting that they may play a protective
or regenerative role following injury [4–7, reviewed in 8].
Immunophilins have also been associated with the processing of
Alzheimer’s Amyloid Precursor Protein (APP), which can be
processed in an amyloidogenic or non-amyloidogenic manner.
Overexpression of Pin1, a member of the parvulin family of
immunophilins [9], reduces Ab and knockout of Pin1 increases Ab
production in Alzheimer’s disease brains, through the isomeriza-
tion of the cytoplasmic domain of APP at a phosphorylated
Thr668/Pro motif [10]. In addition, the APP intracellular domain
(AICD) interacts with the peptidyl prolyl isomerase domain of the
smaller immunophilin FKBP12 [11].
We have previously explored the existence of additional
FKBP52-interacting cellular factors in neuronal cells and found
that FKBP52 interacts with Atox1, a metallochaperone for copper
[12]. In these studies, expression of FKBP52 in mammalian cells
caused lower levels of intracellular copper, suggesting that
FKBP52 facilitates copper efflux [12]. Metal dys-homeostasis is
instrumental in the pathology of Alzheimer’s disease and copper
interactions with APP and Ab, both of which contain copper-
binding sites, have been widely documented and implicated in the
disease [13–14; reviewed in 15]. Although the direct interaction of
copper and Ab is believed to be important for the aggregation and
toxicity of the peptide, the copper/Ab interactions in vivo are
complex and multifactorial. In particular, disturbances in both the
intracellular compartmentalization of copper as well as in its
extracellularly released forms may contribute to Ab production
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has been shown to alter levels of Ab in transgenic mice [17–18],
although it is not clear whether this is a function of reduced Ab
production or enhanced clearance of the peptide.
Given the importance of copper homeostasis in Alzheimer’s
disease pathology and our findings and published studies that
immunophilins may participate in both of these processes, we
examined if FKBP52 might affect Alzheimer’s-related processes.
To test this, we explored the function of FKBP52 using Drosophila
genetics and found that mutations in FKBP52 exacerbate Ab
toxicity while transgenic flies that overexpress wild type FKBP52
decrease Ab toxicity. The effects on Ab phenotypes correlated
with altered levels of the peptide, suggesting that FKBP52 may
affect Ab turnover. We also provide genetic and biochemical
evidence that these effects of FKBP52 can be modulated by altering
copper homeostasis during development. Finally, we also provide
evidence that FKBP52 binds APP in mammalian cells and alters
levels of Ab. Taken together, our data identify a novel role for
FKBP52 in Alzheimer’s disease, and suggests that this high
molecular weight immunophilin acts on multiple aspects of Ab
metabolism and toxicity.
Methods
Drosophila Strains, Rearing and Phenotypic Analysis
All flies were kept on yeast-containing media and were raised at
25uCo r2 9 uC. dFKBP59 and Atox1 mutations were obtained from
the Bloomington Drosophila Stock center (http://flystocks.bio.
indiana.edu). UAS-Ctr1A flies are described in [19] and do not alter
eye morphology when overexpressed (Fig. S1J). Based on
information from Flybase [20] and our own analyses,
dFKBP59
c01413, dFKBP59
k00424 and dFKBP59
k09010 are viable loss-
of-function mutants and have no effect on the morphology of the
eye (Fig. 1A and Fig. S1E-F). Knock-out mutations of the mouse
dFKBP52 gene are viable as well. The fact that three different
insertional mutants in dFKBP59 cause the same phenotype in Ab
flies supports the involvement of this gene in Ab toxicity.
dFKBP59
EY03538 causes 2.9-fold up-regulation of the transcript in
the presence of Gal4 protein (Fig. S2A) and does not alter eye
morphology when overexpressed (Fig. S1K). Atox1
e01272,
Atox1
EY15780 and Atox1
f00729 are also loss of function mutations
(Flybase, [20]), which do not affect eye morphology (Fig. S1G–I).
Generation of the GMR-Ab42 and UAS-Ab42 flies is described in
[21]. The UAS-Ab42 flies used in the lifespan analysis carry
additional copies of the transgene, generated by re-mobilization of
the original insertion. Additional production of Ab42 peptides
accounts for their dramatically reduced lifespan. Expression of the
Ab42 transgene in these flies was induced with the elavGal4 driver
strain, which confers pan-neuronal expression [22]. Life-span
monitoring was performed as described in [21] and Kaplan-Meier
analysis was used to estimate lifespan probability for each genotype
and feeding regimen. Time to event was defined as the lifespan for
each fly. P-values were calculated using the log rank test on Stata
Statistical Software, version 10 (StataCorp. 2007 College Station,
TX: StataCorp LP). For the eye phenotype, flies were scored after
aging to ,15–20 days old. The Ab42 effects are quantified by the
severity of the rough eye phenotype, as previously [23]. When
modifier mutations are co-expressed in Ab42-expressing flies, the
distribution of phenotypes is shifted to more mild phenotypes in
the case of a suppressor, or more severe phenotypes in a case of an
enhancer (Fig. S1A–C and Table 1). ,100 flies were scored per
genotype and each experiment was repeated 2 or 3 times and
evaluated by a two-tail, two sample-equal variance Student’s
T-test.
Cu Feeding and Measurements
Males and female flies of the appropriate genotypes were put on
food supplemented with CuCl2 or the heavy metal chelator,
bathocuproinedisulfonic acid (BCS; Sigma-Aldrich, St Louis, MO)
as indicated. Progeny grew and were aged on the supplemented
Figure 1. Effects of dFKBP59 mutations on Ab42 toxicity in Drosophila. (A–D) Eye phenotypes. (A) wild-type eyes of FKBP59
c01413/FKBP59
c01413
flies. (B) rough-eye phenotype of Ab flies. (C) enhanced rough-eye phenotype of Ab flies carrying the loss-of-function mutation dFKBP59
c01413. (D)
suppressed rough-eye phenotype of Ab flies carrying the gain-of-function mutation dFKBP59
EY03538. (E–F) Lifespan analysis of Ab flies carrying
dFKBP59 mutations. (E) CNS-directed expression of Ab42 (blue) causes a shorter lifespan compared to flies expressing only the elavGal4 driver (green).
(F) A gain-of-function mutation in dFKBP59 rescues the Ab phenotype. Comparison of Ab-only (blue) and Ab/dFKBP59
EY03538 (red). (G) A loss-of-
function mutation in dFKBP59 rescues the Ab phenotype. Comparison of Ab-only (blue) and Ab/dFKBP59
c01413 (red). (H) Over-expression of FKBP59
(FKBP59gof) in 15–17 day old Ab42- expressing flies reduces the levels of total Ab42.
doi:10.1371/journal.pone.0008626.g001
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15–17 day old fly heads were digested in 10 ml of 5% nitric acid,
with a microwave sample digester CEM Mars 2000 using a
modified oyster tissue method. Cu was measured using ICP-MS
on a Thermo-elemental X5 instrument. Standard solutions were
prepared in 5% HNO3. Cu65 was measured and each sample was
assayed 3 times per ICP-MS run (variation 5–8%). For the wild-
type oreR and Ab42 flies, the average of 4 independent pools was
calculated, showing an average maximum variation around 25–
30%, which includes 15% inherent variation of the ICP-MS
method. In cultured cells, growth media, and wash media, copper
concentrations were determined by electrothermal heated graphite
atomizer (HGA) atomic absorption spectrophotometry with a
Perkin Elmer Zeeman Model 5100 instrument. Previously
described methods [24] were optimized for the instrument, cells,
and media specimens. Counted cell populations of 229610
6 cells
were washed with low Cu media and transferred to Eppendorf
Safe-Lock (1.5 ml) tubes for digestion. Cells were dried for 1 hour
in a heating block at 80uC. The pellet was digested with 100 mLo f
double-distilled 70% nitric acid (GFS Chemical, Powell, OH),
capped and heated overnight at 80uC. The cell digests were
diluted with deionized/distilled water prior to analysis. Media was
analyzed directly with the addition of an ammonium nitrate
modifier to reduce NaCl background interference. A standard
reference material that has a known and certified copper
concentration (NIST 1571), was purchased from the National
Institute for Standards and Technology, and used as quality
control specimen. Blanks were also analyzed with each set of
media and cell samples. Plasticware used for specimen collection,
processing and analysis was acid soaked and rinsed with distilled
water prior to use.
Protein Analysis
Cultured cells were lysed in lysis buffer (20 mM Tris-HCl,
150 mM NaCl, 10 mM Na4P2O7, 2 mM Na3VO4, 1% Triton X-
100, 1 mM PMSF, 20 mg/ml aprotinin). For immunoprecipitation
(IP), 0.5,1.0 mg of total cellular protein was incubated with
primary antibody at 4uC overnight, followed by the addition of
Protein A/G-Sepharoses and additional incubation at 4uC for 1 h,
then resolved by Tris-Tricine gel or SDS-PAGE. Western blotting
of cell samples was performed following SDS-PAGE or Tris-
Tricine gel electrophoresis and transfer to polyvinylidene difluor-
ide membranes (Milllipore, Billerica, MA). Blots were incubated
with primary antibodies, diluted in 5% milk, after which the blots
were washed in Tris-buffered saline containing 0.05% Tween 20
and subsequently incubated with horseradish peroxidase-conju-
gated secondary antibodies. Immunoblots were developed with an
enhanced chemiluminescence kit (Western Lightning; PerkinEl-
mer Life Science, Waltham, MA).
Cell Culture
Human epithelial kidney cells (HEK) were grown in DMEM
containing 10% (v/v) FBS at 37uCi n5 %C O 2. Human
neuroblastoma cells (SH-SY5Y) were grown in MEM/F12 (1:1)
containing 10%(v/v) FBS, 1 mM sodium pyruvate and nonessen-
tial amino acids at 37uCi n5 %C O 2. Wild type and FKBP52
knockout mouse embryonic fibroblast cells (MEF) were kindly
provided by Dr. David Smith (Mayo Clinic, Scottsdale, Arizona)
and were grown in MEM containing 10% (v/v) FBS at 37uCi n
5% CO2.
Plasmids
Full-length human FKBP52, pCxneo-FKBP52-V5, was generated
as described [12]. Full-length human APP, pCEP4-APP695,
containing myc-tag and flag-tag, was a generous gift from Dr.
G. Multhaup (University of Heidelberg) and pcDNA-APP695
containing flag tag was a generous gift from Dr. T. Mizushima
(Kumamoto University). FKBP52 domain I-II fragment (amino
acids 1-261) was subcloned by digested pCxneo-FKBP52 –V5 with
EcoRI into pTracer-EF/V5-His for mammalian expression.
Antibodies
Polyclonal anti-FKBP52 antibody was purchased from Biomol
(Plymouth Meeting, PA) and monoclonal anti-FKBP52 antibody
was purchased from Stressgen (Ann Arbor, MI). Polyclonal anti-
APP antibody (A8717) and monoclonal anti-b-amyloid (6E10)
antibody were purchased from Sigma-Aldrich (St Louis, MO).
Monoclonal anti-FLAG tag antibody (M2), monoclonal anti-V5
tag antibody and monoclonal anti-Myc tag (9E10) were purchased
from Sigma-Aldrich (St Louis, MO), Invitrogen (Carlsbad, CA)
and Santa Cruz Biotechnology (Santa Cruz, CA).
Table 1. Effects of dFKBP59 and copper transporter mutations on the Ab42-induced rough eye phenotype.
Mutation type Rough eye phenotype (%6SEM) Effect
mild moderate severe
(29uC)*** Ab only -- 27602 9 . 5 61.5 4361- -
UAS-Ctr1A gof * 2.562.5 p,0.01 10.262.3 p,0.02 87.2564.8 p,0.01 enhancer
dFKbp59
EY03538 gof 54.569.6 p,0.1 2665p ,0.5 1965p ,0.04 suppressor
(25uC) Abonly -- 50674 7 . 5 65.5 2.261.8 --
Atox1
e01272 lof ** 15.6768.95 p,0.07 2865.1 p,0.08 56.0069.5 p,0.02 enhancer
Atox1
EY15780 lof 12.3366.9 p,0.03 27.6761.33 p,0.02 60.3367.3 p,0.009 enhancer
Atox1
f00729 lof 14.565.5 p,0.05 5762p ,0.2 28.563.53 p,0.02 enhancer
dFKbp59
c01413 lof 1166p ,0.02 22.768.2 p,0.1 66.368.77 p,0.01 enhancer
dFKbp59
k00424 lof 42.569.6 p,0.6 43.569.6 p,0.7 13.560.5 p,0.02 enhancer
dFKbp59
k09010 lof 15.5615.6 p,0.1 4866p ,0.9 36.569.6 p,0.07 enhancer
*gain-of-function mutation.
**loss-of-function mutation.
***For maximum expression, flies with the UAS/Gal4 system were raised at 29uC. All loss-of-function mutants were raised at 25uC.
doi:10.1371/journal.pone.0008626.t001
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All cell lines were transiently transfected using Lipofectamine
2000 (Invitrogen, Carlsbad, CA). To generate the stable expressing
human APP695 in HEK cells, we transfected with pcDNA-APP695,
selected by immunoblotting and maintained positive clones in the
presence of 200 mg/ml G418 (Gibco- Invitrogen, Carlsbad, CA).
To generate the stable expressing human APP695 in FKBP52
knockout mouse embryonic fibroblast (MEF) cells, we co-
transfected with pcDNA-APP695 and pBabe vector, selected by
immunoblotting and maintained positive clones in the presence of
3 mg/ml puromycin (Invitrogen, Carlsbad, CA).
ELISA for Ab Peptides
Levels of Ab peptides in Drosophila heads shown in Fig. 1H
were analyzed as described in [21]. For the analysis of Ab peptides
in mammalian cells, stable APP695-HEK cells or stable APP695-
FKBP52 knockout MEF cells were transiently transfected with
vector or FKBP52-V5 plasmid for 48 hrs. The medium was
changed and the conditioned medium was collected. Medium was
centrifuged for 10 min at 13000 rpm to remove cellular debris and
adjusted to 25 mM Tris-HCl (pH 7.5) containing 1 mM PMSF,
20 mg/ml aprotinin and 0.5% TritonX100. To measure concen-
tration of Ab40 or Ab42, medium was analyzed using an ELISA
kit (Covance Research Products Inc. Dedham, MA).
Results
FKBP52 Modifies the Toxic Effects and Levels of Ab
Peptides in Drosophila melanogaster
We first investigated the effect of FKBP52 on the toxicity of Ab
peptides, by a functional genetic approach. We have previously
engineered transgenic Drosophila melanogaster strains that express
human Ab42 peptides and shown that Ab expression promotes
degeneration of the nervous system with concomitant learning and
memory defects, in a dose dependent manner [22,25]. When Ab is
expressed using an eye-specific promoter, it induces a rough eye
phenotype characteristic of inappropriate organization of omma-
tidia (Fig. 1A–B), whereas expression in the CNS causes reduced
lifespan (Fig. 1E). These phenotypes are caused by progressive
degeneration of the eye and brain tissue, respectively. We
performed genetic interaction analysis in these Ab-expressing flies
by analyzing the modification of Ab-induced phenotypes in the
presence of FKBP52 mutations. Drosophila encodes four known
members of the FKBP family [20]. Two of those are homologs of
the smaller form (FKBP12, FKBP13), one resembles the atypical
form FKBP39 and the fourth member, dFKBP59 [26], is a homolog
of FKBP52, containing three FK506 binding domains and three
tetratricopeptide repeats (TPR).
Shown in Table 1 are Drosophila strains that carry mutations
caused by transposable element insertions in the Drosophila
dFKBP59 gene. We generated flies co-expressing Ab42 with each
of these dFKBP59 mutations and quantified their Ab42-induced
rough eye phenotype (as described in Methods and Fig. 1SA–C).
We found that the loss-of-function mutation dFKBP59
c01413 caused
enhancement of this phenotype (Fig. 1C), whereas the mutant
dFKBP59
EY03538, which over-expresses dFKBP59, suppressed the
Ab42-induced rough eye phenotype (Fig. 1D). Two additional loss
of function dFKBP59 mutations were examined, one causing a
strong enhancement (dFKBP59
k00424) and the second causing a
marginal enhancement (dFKBP59
k09010)o fA b toxicity (Table 1).
All loss of function alleles of dFKBP59 have wild-type eyes (Fig. 1A,
Fig. S1E–F). To further examine this effect, we also tested if
dFKBP59 mutations might alter the lifespan of Ab42-expressing
flies. Figures 1F-G show a comparison between Ab42-expressing
flies with or without a mutation in dFKBP59. In the presence of the
gain-of-function mutation dFKBP59
EY03538, the lifespan of Ab42-
expressing flies was extended significantly (Fig. 1F; P=0.0001),
suggesting that the dFKBP59 mutation had a beneficial effect on
Ab42 toxicity. We also tested the loss-of-function mutation
dFKBP59
c01413 in the same assay and found that it caused the
opposite effect (Fig. 1G; P=0.04), although this was milder than
the effect of the gain of function mutation. This could be due to
different expressivity of the mutations.
Our results indicate that FKBP52/dFKBP59 may function
independently of its role as a prolyl-isomerase to modify Ab
toxicity, as Ab does not contain proline residues. Alternatively,
dFKBP59 might indirectly affect Ab phenotypes. In order to
further analyze the dFKBP659 effects on Ab42, we measured levels
of Ab42 peptides in Drosophila heads over-expressing Ab and
dFKBP59. As shown in Fig. 1H, these flies (Abeta/FKBP59gof)
have significantly lower steady state levels of Ab peptides,
consistent with their suppressed eye and lifespan phenotypes.
The results of our genetic analysis suggest that dFKBP59 can
modify the toxic phenotypes of Ab42 peptides by affecting the
levels of the peptide.
Copper Homeostasis Is Linked to Toxicity of Ab42 in Flies
Our previous studies indicated a role for FKBP52 in the
regulation of intracellular copper metabolism [12]. Since altered
copper homeostasis has clearly been shown to have a role in
Alzheimer’s disease [reviewed in 15], we examined whether it
might impinge on the toxicity of Ab in our model system. For this,
we manipulated copper levels in Drosophila using two indepen-
dent approaches and examined effects on Ab42-induced pheno-
types. In the first approach, we increased or decreased available
copper by either raising flies in food supplemented with copper or
the metal chelator BCS, respectively. In the second approach, we
examined toxicity of Ab in genetic backgrounds where copper
transporter genes were mutated.
Copper-supplemented food does not affect the morphology of
the eyes of wild type flies (Fig. 2A). However, Ab42 flies raised on
1 mM copper had more severe rough eye phenotypes (Fig. 2C)
than Ab42 flies raised on normal food (Fig. 2B). Fig. 2E shows that
,70% of flies fed 1 mM copper had severe rough eyes, whereas
only ,20% of flies raised on normal food had severe rough eyes,
suggesting that copper increased the toxicity of Ab42 peptides. In
order to reduce the amount of available copper, we raised flies on
food supplemented with the chelator BCS. Since BCS shows
minimal toxicity when fed to flies (data not shown), we fed 1 mM
and 5 mM BCS to freshly eclosed flies with eye-specific Ab42
expression. We examined flies aged to 25 days old and found that
BCS feeding ameliorated the Ab-induced rough eye phenotype
(Fig. 2D). Control flies raised on normal food had only moderate
and severe eye phenotypes whereas flies fed 1 mM or 5 mM BCS
also had mild phenotypes (18% and 25% of the progeny,
respectively; Fig. 2F). These experiments demonstrate that altered
Cu levels can directly alter Ab toxicity in flies.
In order to quantify the increase of Cu levels in flies raised on
copper-supplemented food, we used ICP-MS to measure copper in
fly heads. As shown in Fig. 2G, supplementing the fly food with
0.03 mM or 0.3 mM of copper causes an increase in the steady
state levels of copper in Drosophila heads, in a dose dependent
manner (6,340 ng/g in 0.03CumM and 13,860 ng/g in 0.3 mM
copper, as compared to 3,500 ng/g in flies fed normal food).
Expression of Ab42 does not affect the steady state levels of copper
in fly heads, which contain less than one third of copper compared
to the rest of the body (Fig. S2B). More than 75% of the metal is
found in the insoluble fraction of head extracts (Fig. S2C).
FKBP52 and Alzheimer’s
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Modify Ab42-Induced Rough Eye Phenotypes and Alter
Levels of Copper
In order to further analyze the interaction of copper with Ab,
we tested the effects of the Cu transporter genes Ctr1A and Atox1
on Ab phenotypes. Flies express three isoforms of Copper transporter
1 [Ctr1; 27; reviewed in 28], which is a transmembrane protein
responsible for import of copper ions into the cell [reviewed in 29].
In addition, Drosophila carries a homolog of Atox1 [20], which is a
cytoplasmic chaperone responsible for delivery of copper to
copper transporting ATPases and hence to the secretory pathway.
We first examined the rough-eye phenotype of Drosophila over-
expressing Ctr1A and Ab42 and found that it was enhanced,
compared to flies expressing only Ab42 (Table 1). Given the role of
Ctr1A in importing Cu into the cell, we hypothesized that the Ctr1A
effects might be mediated by higher levels of available copper. To
test this, we measured the amount of copper in heads of flies over-
expressing the copper transporters Ctr1A under the control of the
UAS/Gal4 system [30] and found a 4-fold increase in the levels of
copper, as compared to control heads (Fig. 3A). The fact that over-
expression of Ctr1A caused elevated levels of copper supports our
hypothesis that the enhancement of the Ab42 phenotype when this
transporter is over-expressed may be due to the presence of
elevated copper levels in the cell.
We then examined how mutations in Atox1 are affecting the
Ab42 phenotype. Table 1 shows that three different loss-of-
function alleles of the Atox1 gene, Atox1
e01272, Atox1
EY15780, and
Atox1
f00729 cause enhancement of the Ab42 rough eye phenotype.
Atox1 loss of function mutations do not affect eye morphology
(Fig. S1G–I). Since Atox1 is involved in the delivery of copper to
copper-transporting ATPases in the trans Golgi network (TGN),
perturbations in its expression would disturb the proper localiza-
tion of copper in the cell, potentially exacerbating Ab toxicity.
Supporting this, we found that Atox1 loss-of-function mutants had
more copper than control flies (Fig. 3B). Since we have previously
shown that dFKBP59 interacts with Atox1 and is involved in
copper efflux [12], we tested levels of copper in loss of function
dFKBP59 mutant Drosophila heads and found that they had
increased levels of copper (Fig. 3B). Although all loss of function
mutations of Atox1 and dFKBP59 that we examined increased
levels of copper, the increases were of varying degrees, perhaps
reflecting genetic background effects. It is worth noting however,
that the three mutants with the strongest phenotypic effects on
Ab42, Atox1
EY15780, Atox1
f00729 and dFKBP59
c01413, showed the
higher increases in levels of copper.
We showed the same effects of loss of FKBP52 function on
copper levels, in mammalian cells. Changes in copper levels can be
measured in MEF cells treated with 50 mM or 100 mM of the
chelator BCS, as shown in Fig. 3C. Using this assay, we showed
that immortalized MEF cells obtained from FKBP52 null mice
[FKBP52(2/2)] had elevated copper compared to wild type MEF
cells (48 pmol/10
6 cells versus 31 pmol/10
6 cells; p=0.05;
Fig. 3D), confirming our previous observations that over-
expression of FKBP52 causes lower levels of copper [12]. These
experiments further support the involvement of FKBP52 in copper
homeostasis and suggest that changes in levels of cellular copper by
mutations in FKBP52 may potentiate the toxic effects of Ab.
Synergy between Immunophilin FKBP52 and Copper
Homeostasis Moderates Ab42 Toxicity
We next performed a genetic interaction analysis, to test
whether the effect of dFKBP59 on Ab toxicity might be dependent
on copper homeostasis. If this were true, we should be able to
detect an epistatic relationship between available copper levels and
functions of dFKBP59, using as a read-out the Ab42-induced
phenotypes in flies. We chose to manipulate the levels of copper by
Figure 2. Effects of copper on Ab42 phenotypes. (A–D) Eye phenotypes of 15–17 day old flies. (A) wild type flies on 1 mM Cu (B) Ab flies on
normal food. (C) Ab flies on food supplemented with 1 mM Cu. (D) Ab flies on food supplemented with 1 mM BCS. (E–F) Quantification of the effects
of Cu (E) and BCS (F) feeding on the rough eye phenotype. Phenotypes were evaluated as mild (light gray), moderate (dark gray) or severe (black) and
the percent distribution of these phenotypes is shown. The graphs show a shift in the distribution of phenotypes when flies are raised on
supplemented food. (G) Dose-dependent increase in levels of copper in flies raised on Cu-supplemented food.
doi:10.1371/journal.pone.0008626.g002
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we showed above, improves Ab42 phenotypes. Our experimental
progeny was expressing Ab42 in the presence of either over-
expression or loss-of-function mutations of dFKBP59 and was
tested for effects on the lifespan phenotype, which provides a
measure of CNS function.
As a control, we treated Ab-expressing flies with BCS and
observed a beneficial effect on their lifespan (Fig. 4A). We next
treated Ab flies carrying a loss-of-function mutation of dFKBP59,
which showed a highly significant increase in lifespan, relative to
non-BCS treated flies (Fig. 4B; P=0.0001). Similarly, treated Ab
flies over-expressing dFKBP59 showed significantly increased
lifespan versus non-treated flies (Fig. 4C; P=0.0004). The fact
that this increase in lifespan is more evident towards the later
stages of life may indicate that the effects are dependent on specific
levels and/or nature of Ab oligomeric species. These results
suggest that levels of intracellular copper influence the effects of
dFKBP59 on Ab42 toxicity.
Role of FKBP52 in Ab Metabolism in Mammalian Cells
We next investigated whether FKBP52 affected Ab levels in
mammalian cells expressing APP. Previous studies have suggested
a role for other members of the prolyl-isomerase family, such as
FKBP12 and Pin1, in promoting the non-amyloidogenic process-
ing of APP [reviewed in 31]. However, no previous study has
addressed the involvement of the larger immunophilin FKBP52 in
this pathway.
To test the effect of FKBP52, we transiently transfected FKBP52
in HEK cells that had stable expression of APP695 (Fig. 4D) and
assayed levels of Ab in the conditioned media with an ELISA
assay. Fig. 4E shows that overexpression of FKBP52 reduced the
levels of Ab42 peptides in stable APP695-HEK cells. We also
transfected human FKBP52 in FKBP52-knockout APP695-MEF
cells (Fig. 4F) and found that in these cells, Ab42 levels were also
less than those in FKBP52 knockout cells not transfected with
human FKBP52 (Fig. 4G). The fact that HEK cells with wild-type
FKBP52 and MEF cells with FKBP52 knockout produce the same
amount of Ab may be due to different steady state levels of Ab in
HEK versus MEF cells. These results suggest that, as in
Drosophila, FKBP52 reduces levels of Ab in mammalian cells as
well.
FKBP52 Interacts with APP
We subsequently investigated whether FKBP52 and APP
interact physically. We co-transfected Myc-APP695-FLAG and
FKBP52-V5 into HEK cells. As is seen in Fig. 5A, using
immunoprecipitation with appropriate antibodies, we were able
to detect an interaction between the two proteins. We confirmed
this interaction by also testing the pools of endogenous proteins in
these cells. As HEK cells express both endogenous APP and
FKBP52, they are suitable for testing the in vivo interaction of APP
and FKBP52 (Fig. 5B). Using co-immunoprecipitation, we
detected evidence for an interaction between endogenous APP
and FKBP52, in cell lysates of HEK cells (Fig. 5C), confirming the
results that we obtained with the transfected forms of the two
proteins. This interaction was blocked after treatment of the cells
with 0.5 mM FK506 (Fig. 5C). Thus, similar to the smaller
immunophilin, FKBP12, the larger protein FKBP52 is interacting
with APP.
We next sought to determine which domain of FKBP52 is
responsible for the interaction with APP. Guided by the
interaction of the PPIase domain of FKBP12 with APP, we
cloned and transfected the truncated domain I-II of FKBP52,
which encompasses amino-acids 1–261 and contains a PPIase
domain. As shown in Fig. 5D, the truncated domain of FKBP52
bound APP in a similar fashion to the binding of the full length
protein, suggesting that the interaction of FKBP52 with APP is
mediated by the PPIase domain. Domain I of FKBP52 associates
with various cellular factors, including the glucocorticoid receptor
[1,32] dynein [33], the transient receptor potential channel [TRP;
34], and Atox1 [12]. With the exception of dynein, most of these
factors dissociate from FKBP52 after addition of FK506. Since we
Figure 3. Mutations in Ctr1, Atox1 and dFKBP59 alter levels of Cu in Drosophila heads and mouse cells. (A–B) Copper measurements in
Drosophila heads. (A) Control flies (oreR), flies expressing Ab42 (Abeta) or flies over-expressing Ctr1A (UAS-Ctr1). (B) Wild type flies (oreR) and flies
carrying loss-of-function mutations in the Atox1 and FKBP59 genes. Stars denote statistical significance. (C–D) Copper measurements in MEF cells. (C)
intracellular copper in cells treated with BCS. (D) Intracellular copper in FKBP52 knock-out MEF cells.
doi:10.1371/journal.pone.0008626.g003
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APP/FKBP52 complex (Fig. 5C), we suggest that the PPIase
domain plays a direct role in the FKBP52/APP interaction.
Discussion
The high molecular weight immunophilin FKBP52 belongs to a
family of versatile multi-domain proteins that are abundantly
expressed in the nervous system and often show increased
expression in damaged or degenerating brain regions. In the
present study, we have identified a novel function of FKBP52 in
Ab-mediated toxicity using a genetic model in Drosophila that
expresses Ab42 peptides. The protective effect of FKBP52 on Ab
toxicity during Drosophila aging was evident from the observations
that FKBP52 loss of function mutations potentiated Ab toxicity,
while over-expression of FKBP52 delayed or suppressed Ab-
induced phenotypes. Moreover, through genetic interactions and
chemical approaches, we also found evidence that the effects of
FKBP52 may be modulated by changes in intracellular copper
homeostasis. These observations are consistent with our previous
reports that FKBP52 interacts with the copper efflux machinery,
and as such, establish a new aspect of involvement of the
immunophilin family in Alzheimer’s-related mechanisms. Several
lines of evidence link the protective effects of FKBP52 with
intracellular copper homeostasis. First, FKBP52 directly interacts
with the copper metallochaperone Atox1 [12], a protein that
delivers copper to the copper transporting ATPAses ATP7A and
ATP7B [reviewed in 35]. Second, through genetic screens in this
study, we found that mutations in the copper transport genes Ctr1A
and Atox1, which directly regulate intracellular copper levels,
modify Ab-induced phenotypes in Drosophila. Third, chemical
manipulation of dietary copper levels also decreases or increases,
respectively, the protective effect of FKBP52 on Ab toxicity.
Finally, MEF cells isolated from FKBP52(2/2) mice show
increased levels of copper compared to wild type MEF cells and
over-expression of FKBP52 causes efflux of copper [12].
The metallobiology of copper plays a significant role in several
neurodegenerative conditions. Interestingly, copper influences the
aggregation properties of ‘‘toxic peptides’’ that contribute to these
conditions, including beta amyloid, prion protein and a-synuclein
as all three of these agents can bind copper ions [reviewed in 36].
The presence of copper in mildly acidic conditions induces
aggregation of the Ab peptide [13] and may exacerbate pathology
linked to Ab deposition. Our experiments show that all genetic
manipulations that increased levels of copper, also enhanced the
Ab phenotypes. Copper manipulations were mediated either by
increased copper entry, through over-expression of the plasma
membrane transporter Ctr1A, or by misregulation of cytoplasmic
copper trafficking through loss-of-function mutations of the Atox1
and FKBP52 genes. The enhancement of Ab phenotypes by
increasing dietary copper also supports these observations. Since
copper is delivered to the trans-Golgi network (TGN) by the
Figure 4. Interaction of dFKBP59 and copper and effects on Ab levels. (A–C) Lifespan analysis of Ab flies carrying mutations in dFKBP59 and
raised on normal food or food supplemented with 1 mM BCS. (A) Ab/BCS flies (green) compared to Ab flies (blue). (B) Ab/dFKBP59
lof flies (red)
compared to Ab/dFKBP59
lof/BCS flies (green). (C) Ab/dFKBP59
gof flies (red) compared to Ab/dFKBP59
gof/BCS flies (green). (D) APP and FKBP52
expression in APP695-HEK cells transiently transfected with FKBP52. (E) Ab levels in conditioned medium collected after 24 h from cells in (D). (F) APP
and FKBP52 expression in APP695-FKBP52 knockout MEF cells transiently transfected with FKBP52. (G) Ab levels in conditioned medium collected
after 48 h from cells in (F).
doi:10.1371/journal.pone.0008626.g004
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of Ab with copper may at least partially take place in the TGN.
Given the mildly acidic pH of the TGN [37–38], increased levels
of copper in this compartment would lead to enhancement of Ab
toxicity and result in more severe Ab-induced phenotypes, possibly
through the induction of oxidative stress. Supporting the role of
oxidative damage, over-expression of the anti-oxidative stress gene
ferritin heavy chain suppressed the Ab42-induced short lifespan in
Drosophila [39]. We further found that flies over-expressing
dFKBP59 had lower levels of Ab peptides, consistent with their
suppressed phenotypes. Based on this, we suggest that dFKBP59
over-expression leads to increased Ab turnover.
The interaction of FKBP52 with the transporter Atox1 presents
a novel aspect of copper metabolism. FKBP52 participates in
many cellular processes, including the translocation of steroid
receptor complexes to the nucleus through interactions with
dynein [reviewed in 40]. FKBP52 also has chaperone activity
shown by suppression of the aggregation of heat-denatured citrate
synthase [41]. We propose that FKBP52 may be required for the
proper function of Atox1. Further analysis using double mutants of
Atox1 and FKBP52 and examining their effects on Ab toxicity
would be needed in order to confirm this hypothesis.
We also examined the effects of FKBP52 in mammalian cells
expressing APP. Unlike Ab, which does not contain proline amino
acids and is not regulated by prolyl isomerization, the APP holo-
enzyme binds the prolyl-isomerase Pin1 in its intracellular tail [10]
and it also interacts with the small immunophilin FKBP12 [11]. In
the current studies we provide evidence that APP also binds
FKBP52, via its FK506 binding domain and that FKBP52(2/2)
cells have higher levels of Ab peptides than the same knock-out
cells reconstituted with FKBP52. The physical interaction of
FKBP52 with APP suggests that this large immunophilin, in
addition to altering Ab levels, may have a role on the metabolism
of APP. The effects of smaller members of the immunophilin
family on the processing of APP would support such a role and
future experimentation will address this hypothesis. In support of
this novel role of immunophilins, we showed recently that a
mutation in the Drosophila Ryanodine receptor homolog Rya-r44F could
modify a APP-overexpression associated phenotype [42]. The
FKBP12 protein interacts with ryanodine receptors [43], further
implicating signaling through the immunophilin famlily with APP
metabolism.
In summary, our studies show that the large immunophilin
FKBP52 modulates Ab toxicity, possibly through a mechanism
that involves homeostasis of cellular copper. Our data does not
rule out the possibility that the effects of FKBP52 mutations and
metal transport act in parallel pathways, however, it provides
indirect evidence for a possible mechanistic link between these
respective pathways. Examination of effects of Ab in FKBP52
knock-out mice will further validate our observations. The
function of immunophilins is modulated by the FK506 family of
ligands, several members of which have been developed to bind
their targets without causing immune suppression. It will be
interesting to examine if such ligands can modify the interaction of
FKBP52 with APP and Ab. We have evidence that the FK506-
binding domain of FKBP52 is involved in the binding with APP,
Figure 5. FKBP52 interacts with APP in endogenous and overexpression systems. (A) HEK cells were transiently co-transfected with Myc-
APP-FLAG and FKBP52-V5, immuniprecipitated with anti-Myc or anti-FLAG antibody and detected by western blot using anti-V5 antibody or anti-Myc
antibody. (B) Western blot analysis for endogenous expression levels of both APP and FKBP52 in whole-cell lysates from human neuroblastoma cell
(SH-SY5Y) and Human Kidney Epithelial cell (HEK). (C) HEK cells were treated with or without 0.5 mM FK506 for 5 hr and immunoprecipitated with
anti-APP antibody followed by western blot using anti FKBP52 antibody. Expression level of APP or FKBP52 was detected by western blot using anti-
APP or anti-FKBP52 antibody. (D) HEK cells were transiently transfected with full-length FKBP52-V5 or FKBP52 domain I-II-V5 and immunoprecipitated
with anti-APP antibody followed by western blot using an anti V5 antibody.
doi:10.1371/journal.pone.0008626.g005
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interaction. Further studies will show whether these ligands are
also involved in modulating toxicity of Ab and may open the field
for the development of a novel class of agents against Alzheimer’s
disease.
Supporting Information
Figure S1 Eye phenotypes of Ab expressing flies and FKBP59
and Atox1 mutants. (A–C) Rough eye phenotype of Ab42 flies. (A)
Mild, (B) Moderate, (C) Severe. (D–I) wild-type eye phenotype. (D)
wild-type oreR flies, (E) FKBP59
k09010/+ flies, (F) FKBP59
k00424/
+ flies, (G) Atox1
e01272/Atox1
e01272 flies, (H) Atox1
EY15780/
Atox1
EY15780 flies, (I) Atox1
f00729/Atox1
f00729 flies. (J) eyGal/+;
dFKBP59
EY03538/+ flies, (K) eyGal/+; UAS-Ctr1A flies.
Found at: doi:10.1371/journal.pone.0008626.s001 (6.08 MB TIF)
Figure S2 Analysis of dFKBP59 RNA and copper levels. (A)
RNA levels in fly heads over-expressing FKBP59
EY03538 compared
to control flies, measured by real-time PCR analysis, as described
in [21]. (B) Cu concentration in pools of 100 flies, aged to 15 days.
Bodies contain the majority of Cu. (C) Cu concentration in pools
of 60–80 flies, aged to 15 days. Control and flies expressing one or
two copies of the Ab42 transgene were analyzed. From each
sample, the supernatant (containing the soluble fraction) and pellet
(containing the insoluble fraction) were analyzed separately. The
majority of Cu is found in the insoluble fraction.
Found at: doi:10.1371/journal.pone.0008626.s002 (0.79 MB TIF)
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